Wordt geladen...
Circulating PD‐1 (+) cells may participate in immune evasion in peripheral T‐cell lymphoma and chidamide enhance antitumor activity of PD‐1 (+) cells
Peripheral T‐cell lymphoma (PTCL) is a heterogeneous disease with poor outcomes. We intend to explore the role of circulating PD‐1 (+) cells in tumor immune evasion in PTCL patients and the mechanism of chidamide as a regulator of immune‐associated medicine on PD‐1 (+) cells. Gene expression profili...
Bewaard in:
| Gepubliceerd in: | Cancer Med |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536954/ https://ncbi.nlm.nih.gov/pubmed/30969023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2097 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|